跳至主要内容
临床试验/JPRN-UMIN000041324
JPRN-UMIN000041324招募中未知

Early Vascular Response to Ultrathin Biodegradable-Polymer Sirolimus-Eluting Stents for The Treatment of ST-Elevation Myocardial Infarction After Plaque Rupture - BD-SES in STEMI

Showa University School of Medicine, Division of Cardiology, Department of Medicine0 个研究点目标入组 20 人开始时间: 2020年8月6日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • cardiogenic shock, left main disease at the culprit lesion, reference vessel diameter less than 2.0 or 4.5 mm and more, chronic kidney disease defined as a serum creatinine 2.0 mg/dL and more, maintenance dialysis, life expectancy less than two years, planned surgery within three months, adverse reactions to aspirin or clopidogrel previously, warfarin intake before STEMI onset, age less than 20 years, pregnancy, and a previously treated culprit lesion in the stented segment. We further excluded patients who did not undergo OCT, did not show plaque rupture on OCT, and received DES other than BP-SES, patients who do not consent the study.

研究者

发起方
Showa University School of Medicine, Division of Cardiology, Department of Medicine

相似试验